BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1683914)

  • 1. Comparison of alpha 1-adrenoceptors between rat brain and spleen.
    Tsuchihashi H; Maruyama K; Baba S; Mano F; Kinami J; Nagatomo T
    Jpn J Pharmacol; 1991 Aug; 56(4):523-30. PubMed ID: 1683914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-adrenoceptor subtypes in the rat ventricular muscle.
    Kinami J; Tsuchihashi H; Baba S; Mano F; Maruyama K; Nagatomo T
    J Pharm Pharmacol; 1992 Feb; 44(2):97-100. PubMed ID: 1352824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 adrenoceptor subtypes in canine aorta.
    Maruyama K; Ohkura N; Yagi Y; Nagatomo T
    Jpn J Pharmacol; 1993 Jul; 62(3):263-7. PubMed ID: 8105123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of alpha 1-adrenoceptor subtype selectivity by [3H]-prazosin displacement studies in guinea-pig cerebral cortex and rat spleen membranes.
    Veenstra DM; van Buuren KJ; Nijkamp FP
    Br J Pharmacol; 1992 Sep; 107(1):202-6. PubMed ID: 1358383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.
    Kinami J; Tsuchihashi H; Maruyama K; Sasaki K; Nagatomo T
    Jpn J Pharmacol; 1993 Feb; 61(2):81-6. PubMed ID: 7681491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Displacement by alpha-adrenergic agonists and antagonists of 3H-prazosin bound to the alpha-adrenoceptors of the dog aorta and the rat brain.
    Nagatoma T; Tsuchihashi H; Sasaki S; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1985 Feb; 37(2):181-7. PubMed ID: 2860265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
    Büscher R; Heeks C; Taguchi K; Michel MC
    Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for multiple [3H]prazosin binding sites in canine brain membranes.
    Mignot E; Bowersox SS; Maddaluno J; Dement W; Ciaranello R
    Brain Res; 1989 May; 486(1):56-66. PubMed ID: 2541871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.
    Sallés J; Badia A
    Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
    Hanft G; Gross G
    Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.
    Morrow AL; Creese I
    Mol Pharmacol; 1986 Apr; 29(4):321-30. PubMed ID: 3010073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex.
    Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1991 Dec; 104(4):961-5. PubMed ID: 1687370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of alpha 1-adrenoceptors in rat renal cortex: comparison of [3H]-prazosin binding with the alpha 1-adrenoceptor modulating gluconeogenesis under physiological conditions.
    McPherson GA; Summers RJ
    Br J Pharmacol; 1982 Sep; 77(1):177-84. PubMed ID: 6127133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective enrichment with alpha 1A- and alpha 1B-adrenoceptor subtypes in rat brain cortical membranes.
    Sallés J; Badia A
    Eur J Pharmacol; 1994 Feb; 266(3):301-8. PubMed ID: 7909753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
    Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain.
    Miach PJ; Dausse JP; Cardot A; Meyer P
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):23-6. PubMed ID: 6248797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
    J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.
    Greengrass P; Bremner R
    Eur J Pharmacol; 1979 May; 55(3):323-6. PubMed ID: 37098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.